Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's ...
The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...
For companies such as HRV Pharma out of India, the standardized scale of manufacturing has expanded alongside its ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
Lupin Manufacturing Solutions’ Dabhasa facility in India supports API development and commercial-scale manufacturing, forming ...
Key market opportunities include mastering API manufacturing complexities to ensure quality and compliance, navigating EU and USA regulatory frameworks, adhering to GMP and GDP standards, and adapting ...
India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results